Skip to main content
ROVI Subsidiaries
Spain
Germany
France
Italy
Poland
Portugal
United Kingdom
Language
Spanish
Spanish
English
English
English
Español
Home
ROVI
History
Group structure
Business units
International expansion
Strategy
Licenses
Contact
Products
Prescription Pharmaceuticals
Hospital Products
Manufacturing
CDMO
Own product Manufacturing
R&D
Shareholders and Investors
The share
Investor's Calendar
News
Financial and Business Information
CMNV Communications
ESG
Corporate Governance
Telematic assistance access
Prior Registration On-Line Attendance
On-Line Attendance
Sustainability
Responsible governance
Commitment to people
Environmental Commitment
Ethics Channel
Media
FAQS
News
ROVI up to date
Contact
Work with Us
TELEMATIC ASSISTANCE ACCESS
Home
News
Press release for the first quarter of 2017
Fri, 21/04/2017 - 17:34
0 min
2017 Noticia 3.png
Download related document
Select rating
Give Press release for the first quarter of 2017 1/5
Give Press release for the first quarter of 2017 2/5
Give Press release for the first quarter of 2017 3/5
Give Press release for the first quarter of 2017 4/5
Give Press release for the first quarter of 2017 5/5
No votes yet
Related
Full Year 2022 Results Press Release
ROVI REPORTS OPERATING REVENUE GROWTH OF 26% AND EBITDA GROWTH OF 37% Operating revenue increased by 26% to 817.7 million euros...
3 min
21/02/2023
ROVI informs on the evaluation process to obtain marketing authorisation for...
Laboratorios Farmacéuticos ROVI, S.A. (ROVI) informs on the evaluation process to obtain marketing authorisation for Risvan® (Risperidone...
2 min
16/02/2023
ROVI’s Alcalá de Henares plant receives the visit of the Romanian Health...
Madrid, 6th February, 2023 This Monday, the Romanian Minister of Health, Alexandru Rafila, visited the ROVI plant in Alcalá de Henares....
2 min
06/02/2023
See More
Email
Facebook
Twitter
LinkedIn
2017 Noticia 3.png